Mario Mujica-Mota1, Sofia Waissbluth, Sam J Daniel. 1. Division of Otolaryngology-Head and Neck Surgery, The Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Abstract
BACKGROUND: Patients receiving radiotherapy (RT) for head and neck tumors are at risk of developing sensorineural hearing loss. The objective of this study was to analyze the literature regarding sensorineural hearing loss after RT for head and neck cancer. METHODS: Seven databases were searched to identify eligible studies. Eligible articles were independently assessed for quality by 2 authors. RESULTS: Fourteen articles were evaluated. There was considerable heterogeneity among studies. The reported incidence of sensorineural hearing loss (SNHL) varied from 0% to 85% for the speech frequencies and from 27% to 95% for high frequencies. As the follow-up increased, an increase in the incidence of SNHL was observed. The minimum cochlear dose reported to be a risk factor for SNHL was 45 Gy. CONCLUSIONS: High quality literature in the topic is lacking. Radiation-induced SNHL is progressive, permanent, and dose-dependent. Total dose and follow-up time are important factors affecting incidence rates.
BACKGROUND:Patients receiving radiotherapy (RT) for head and neck tumors are at risk of developing sensorineural hearing loss. The objective of this study was to analyze the literature regarding sensorineural hearing loss after RT for head and neck cancer. METHODS: Seven databases were searched to identify eligible studies. Eligible articles were independently assessed for quality by 2 authors. RESULTS: Fourteen articles were evaluated. There was considerable heterogeneity among studies. The reported incidence of sensorineural hearing loss (SNHL) varied from 0% to 85% for the speech frequencies and from 27% to 95% for high frequencies. As the follow-up increased, an increase in the incidence of SNHL was observed. The minimum cochlear dose reported to be a risk factor for SNHL was 45 Gy. CONCLUSIONS: High quality literature in the topic is lacking. Radiation-induced SNHL is progressive, permanent, and dose-dependent. Total dose and follow-up time are important factors affecting incidence rates.
Authors: Meghan Phelan; Susan S Hayashi; Kara Sauerburger; Jennifer Henry; Ningying Wu; Robert J Hayashi Journal: Pediatr Blood Cancer Date: 2021-12-02 Impact factor: 3.167
Authors: Lori Zitelli; Catherine Palmer; Elizabeth Mamula; Jonas Johnson; Grant Rauterkus; Marci L Nilsen Journal: J Cancer Surviv Date: 2022-03-29 Impact factor: 4.442
Authors: Miranda L Camet; Susan S Hayashi; Belinda C Sinks; Jennifer Henry; Katie Gettinger; Ashley Hite; Juliann Kiefer; Caroline Mohrmann; Taryn Sandheinrich; Feng Gao; Robert J Hayashi Journal: Pediatr Blood Cancer Date: 2018-01-30 Impact factor: 3.167
Authors: Matthew R Trendowski; Jessica L Baedke; Yadav Sapkota; Lois B Travis; Xindi Zhang; Omar El Charif; Heather E Wheeler; Wendy M Leisenring; Leslie L Robison; Melissa M Hudson; Lindsay M Morton; Kevin C Oeffinger; Rebecca M Howell; Gregory T Armstrong; Smita Bhatia; M Eileen Dolan Journal: Cancer Date: 2021-07-19 Impact factor: 6.860